Precursor B-cell lymphoblastic lymphoma involving the skin

Journal of Cutaneous Pathology

Volumn 33, Issue 9, 2006, Pages 649-653

  Kim, Ji Yeon ^a   Kim, You Chan ^a   Lee, Eun So ^a,b  

^a Ajou University School of Medicine   (South Korea)

^b NONE   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

AGED; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CLINICAL FEATURE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LYMPHOCYTIC INFILTRATION; MALE; PHYSICAL EXAMINATION; SKIN BIOPSY; SKIN LYMPHOMA; SKIN NODULE;

AGED; ANTIGENS, CD; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, B-CELL; MALE; SKIN NEOPLASMS; STEM CELLS;

EID: 33748521245     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2006.00405.x     Document Type: Article

References (17)

1. Vallant L. Primary cutaneous lymphoblastic lymphoma of non-B, non-T phenotype. Arch Dermatol 1990; 126: 400.
2. Sander CA, Medeiros LJ, Abruzzo LV, Horak ID. Lymphoblastic lymphoma presenting in cutaneous sites: a clinicopathologic analysis of six cases. J Am Acad Dermatol 1991; 25: 1023.
3. Maitra A, McKenna RW, Weinberg AG, Schneider NR, Kroft SH. Precursor B-cell lymphoblastic lymphoma. A study of nine cases lacking blood and bone marrow involvement and review of the literature. Am J Clin Pathol 2001; 115: 868.
4. Lin P, Jones D, Dorfman DM, Medeiros LJ. Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement. Am J Surg Pathol 2000; 24: 1480.
5. Picozzi VJ. Lymphoblastic lymphoma. Semin Oncol 1990; 17: 96.
6. Chimenti S, Fink-Puches R, Peris K, et al. Cutaneous involvement in lymphoblastic lymphoma. J Cutan Pathol 1999; 26: 379.
7. Soslow RA, Baergen RN, Warnke RA. B-lineage lymphoblastic lymphoma is a clinicopathologic entity distinct from other histologically similar aggressive lymphomas with blastic morphology. Cancer 1999; 85: 2648.
8. Kiyokawa N, Sekino T, Matsui T, et al. Diagnostic importance of CD179a/B markers of precursor B-cell lymphoblastic lymphoma. Mod Pathol 2004; 17: 423.
9. Saha V, Eden OB, Hann I. Primary extra-thoracic T-cell non-Hodgkin's lymphoma of childhood. Leukemia 1995; 9: 40.
10. Yeh KH, Cheng AL, Su IJ, et al. Prognostic significance of immunophenotypes in adult lymphoblastic lymphomas. Anticancer Res 1997; 17: 2269.
11. Picozzi VJ, Coleman CN. Lymphoblastic lymphoma. Sem Oncol 1990; 17: 96.
12. Conde-Sterling DA, Aguilera NS, Nandedkar MA, Abbondanzo SL. Immunoperoxidase detection of CD10 in precursor T-lymphoblastic lymphoma/leukemia: a clinicopathologic study of 24 cases. Arch Pathol Lab Med 2000; 124: 704.
13. Li S, Borowitz MJ. CD79a (+) T-cell lymphoblastic lymphoma with coexisting Langerhan's cell histiocytosis. Arch Pathol Lab Med 2001; 125: 958.
14. Gloeckner-Hofmann K, Ottesen K, et al. T-cell/natural killer cell lymphoblastic lymphoma with an unusual coexpression of B-cell antigens. Ann Hematol 2000; 79: 635.
15. Abla O, Naqvi A, YeC, et al. Leptomeningeal precursor B-cell lymphoblastic lymphoma in a child with minimal bone marrow involvement. J Pediatr Hematol Oncol 2004; 26: 469.
16. Rivera GK, Crist WM. Acute lymphoblastic leukemia. In: Hardin RI, Stossel TP, Lux SE, eds. Blood: Principles and Practice of Hematology. Philadelphia: J. B. Lippincott Company, 1995; 750.
17. Millot F, Robert A, Bertrand Y, et al. Cutaneous involvement in children with acute lymphoblastic leukemia or lymphoblastic lymphoma. Pediatrics 1997; 100: 60.